Adam Resnick, PhD
Adam Resnick is the Director of Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia (CHOP) responsible for leading a multidisciplinary team to build and support a scalable, patient-focused healthcare and educational discovery ecosystem on behalf of all children. He i
Phillip Jay Storm, MD
I am chief of the Division of Neurosurgery at The Children’s Hospital of Philadelphia and an attending neurosurgeon specializing in pediatric brain tumors. I operate on every type of brain tumor, but I have a particular interest in low-grade gliomas, medulloblastomas and atypical teratoid rhabdoi
Operations Center for the Children’s Brain Tumor Tissue Consortium, the Children’s Hospital of Philadelphia (CHOP) is currently ranked 1st nationally for their Pediatric Cancer Program by U.S. News & World Report. CHOP’s Biobank is home to the CBTTC’s pediatric brain and CNS tumor biorepository; the largest of its kind on earth.
The Brain Cancer Center at CHOP is staffed by one of the largest pediatric neuro-oncology treatment teams in the U.S., and specializes in a personalized medicine approach in the treatment of childhood brain tumors, neurofibromatosis, and associated tumors. By performing a genomic analysis of every brain tumor, the team is able to zero in on new treatment-relevant pathways for identifying biological factors that predict which patients require intensive versus less intense therapy.
The program has an extensive laboratory and clinical research program designed to identify new therapies for medulloblastoma, gliomas, and infant brain tumors. CHOP also develops a number of institutional clinical trials, and participates in cooperative group clinical trials. Researchers at the Center for Childhood Cancer Research are using state-of-the-art genomic, immunotherapeutic, and targeted molecular approaches to develop new therapies and optimize existing therapies to treat pediatric brain and spinal cord tumors.
Shannon Robins | Clinical Research Coordinatorhttp://www.chop.edu/
Mateusz Koptyra, PhD
Dr. Mateusz Koptyra is a Senior Scientist responsible for initiation, coordination and implementation of scientific projects around the Center’s research units. His team identifies the research demands at the clinical level and creates pipelines for projects to test the research proposals at a pr
Jena Lilly, MS, CCRC
Jena Lilly is the Director of Operations and Strategic Planning for the Center for Data Driven Discovery in Biomedicine. Currently, she leads a team of over 30 people in support of international pediatric oncology research consortiums which combined, include over 25 pediatric hospitals. She is al
Kristina A. Cole, MD, PhD
Kristina Cole, MD, PhD is a pediatric oncologist who has dedicated her career to translational and clinical research, combining her expertise in molecular pathology, cancer genomics, and developmental therapeutics to identify novel treatments for children with cancer. The long-term goal of Dr. Co
Michael J. Fisher, MD
Michael J. Fisher, MD, is Chief of the Section of Neuro-Oncology, Director of the Neuro-Oncology Fellowship Program and Director of the Neurofibromatosis Program at Children's Hospital of Philadelphia. He has a special interest in brain tumors and neurofibromatosis.Areas of Experti
Jane E. Minturn, MD, PhD
Dr. Jane Minturn's research is focused on developing personalized and targeted therapeutics in tumors of the nervous system and understanding the late effects of our therapies in long-term survivors.As part of our approach to identifying new treatments for children with brain tumors,
Jennifer Mason, BA
Jennifer Mason is responsible for the overall project and operations management for multiple projects under the CTU division of the D3b Center at the Children's Hospital of Philadelphia, including the Children’s Brain Tumor Network (CBTN), and autopsy projects. She is also responsible for en
Shannon Robins, BS
Shannon Robins is a Clinical Research Coordinator responsible for patient consenting and enrollment, clinical data management and quality assurance for the Children’s Brain Tumor Network (CBTN). She also oversees a sub-cohort project focused on Neurofibromatosis II research and assists with the L
Catherine Sullivan, BS
I started working at D3b in November of 2018 and am the Research Technician for CBTN. I am responsible for all specimens collected for CBTN at CHOP and for managing all incoming shipments from external CBTN sites. For all specimens collected, I accession the samples into our BioRepository Core fo